Learn more about DecisionDx-SCC and how it improves risk assessment for high-risk cSCC patients.
Hear from experts and learn more about improving risk assessment in patients with high-risk cutaneous squamous cell carcinoma (HRcSCC).
Expert opinions on the treatment and
management of squamous cell carcinoma.
From Diagnosis to Determination: Don's Skin Cancer Journey of Hope, Clarity and a Plan
Meet Don, a skin cancer survivor who turned fear into power with the help of a strong medical team and the DecisionDx-SCC test. From a surprise diagnosis to the emotional relief of being cancer-free, Don shares how knowing his risk gave him the confidence to move forward with clarity, peace of mind.
Explore on-demand webinars
AHNS DecisionDx–SCC Webinar: Identifying the Risk of Metastasis in cSCC and cSCC-HN Patients
Jason Newman, MD, FACS, Professor of Otorhinolaryngology – Head and Neck Surgery, University of Pennsylvania
CME/CE: N/A
Maui Derm DecisionDx-SCC Product Theater: Identifying the Risk of Metastasis in cSCC Patients with One or More Risk Factors.
Faculty: Brent Moody, MD, FACP, FAAD, Fellow, American College of Mohs Surgery
CME/CE: N/A
Enhanced Metastatic Risk Assessment in Cutaneous Squamous Cell Carcinoma with the 40-Gene Expression Profile Test: An Interview with the Lead Author of DecisionDx-SCC’s Validation Study
Sherrif F. Ibrahim, MD, PhD, Assistant Professor, Department of Dermatology, University of Rochester Medical Center
CME/CE: N/A
The DecisionDx-SCC test is a game changer”
Phil Andrews, NP/PA
